GALASSO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.224
EU - Europa 629
AS - Asia 299
SA - Sud America 1
Totale 3.153
Nazione #
US - Stati Uniti d'America 2.223
PL - Polonia 218
CN - Cina 170
IT - Italia 125
UA - Ucraina 88
DE - Germania 73
TR - Turchia 53
GB - Regno Unito 49
SG - Singapore 42
SE - Svezia 28
FI - Finlandia 19
RU - Federazione Russa 15
VN - Vietnam 14
ID - Indonesia 12
BE - Belgio 5
IN - India 3
CZ - Repubblica Ceca 2
FR - Francia 2
HK - Hong Kong 2
NL - Olanda 2
CA - Canada 1
CL - Cile 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 3.153
Città #
Fairfield 396
Woodbridge 298
Warsaw 218
Ashburn 187
Houston 173
Chandler 163
Ann Arbor 129
Seattle 129
Wilmington 124
Cambridge 123
Jacksonville 106
Ferrara 61
Beijing 39
Izmir 39
Addison 33
Nanjing 33
Princeton 31
Milan 30
Shanghai 30
Dearborn 26
San Diego 23
Bremen 22
Singapore 21
Boardman 19
New York 18
Dong Ket 13
Jakarta 12
Nanchang 11
Shenyang 8
London 7
Changsha 6
Jinan 6
Orange 6
Auburn Hills 5
Brussels 5
Jiaxing 5
Mountain View 5
Tianjin 5
Augusta 4
Cagliari 4
Casalecchio Di Reno 4
Des Moines 4
Falls Church 4
Hebei 4
Hefei 4
Leawood 4
Los Angeles 4
San Mateo 4
Zhengzhou 4
Chicago 3
Kunming 3
Lanzhou 3
Norwalk 3
Redwood City 3
Alghero 2
Hong Kong 2
Indiana 2
Massa Fiscaglia 2
Monmouth Junction 2
Mumbai 2
Prescot 2
Redmond 2
Amsterdam 1
Andover 1
Ardabil 1
Barsinghausen 1
Benevento 1
Brno 1
Changchun 1
Chisinau 1
Chiswick 1
Cupertino 1
Edinburgh 1
Gualtieri 1
Guangzhou 1
Haikou 1
Helsinki 1
Ho Chi Minh City 1
Imola 1
Islington 1
Kuala Lumpur 1
Ningbo 1
Potenza 1
Rossano Veneto 1
San Cipriano Picentino 1
Southwark 1
Suwon 1
Taiyuan 1
Toronto 1
Walnut 1
Wuhan 1
Yellow Springs 1
Totale 2.670
Nome #
A systems biology approach to non-coding RNAs: the networks of cancer 184
MicroRNA Expression Signatures in Solid Malignancies 162
Loss of miR-204 expression is a key event in melanoma 159
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 154
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 150
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 150
Identification of microRNA activity by Targets' Reverse EXpression. 146
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 144
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. 140
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 134
null 132
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 122
null 119
GAMES identifies and annotates mutations in next-generation sequencing projects 118
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 115
Reprogramming of miRNA networks in cancer and leukemia 112
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 102
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 99
null 87
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 85
null 80
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 75
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 71
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 70
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 67
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 66
MiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model 60
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 32
Next generation analysis of breast cancer genomes for precision medicine. 25
A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma 22
Non-coding RNAs: a key to future personalized molecular therapy? 18
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. 11
Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease 11
Totale 3.222
Categoria #
all - tutte 12.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020857 97 35 35 128 70 104 90 83 81 80 25 29
2020/2021616 37 51 32 52 66 63 34 66 29 81 66 39
2021/2022325 29 41 20 6 15 17 19 7 10 41 27 93
2022/2023359 30 15 21 49 65 49 29 31 43 6 15 6
2023/2024173 20 21 3 3 4 29 21 19 6 2 4 41
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 3.222